Home › Funds › Sofinnova Investments, Inc. › EWTX
Sofinnova Investments, Inc. position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
Sofinnova Investments, Inc. reported holding 380,923 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$15.5M, representing 0.82% of its reported portfolio and ranking #32 among its reported holdings. Sofinnova Investments, Inc. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s EWTX position evolved
Sofinnova Investments, Inc. first disclosed a stake in EWTX in Q2 2024 at 475,691 shares (US$8.6M). The position peaked in Q2 2026 at 380,923 shares, worth US$15.5M. Across 9 filings, Sofinnova Investments, Inc. increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 380,923 shares valued at US$15.5M — a reduction of -5,575 shares quarter over quarter.. Notable position changes include a 124% increase in Q2 2025 (shares rose 24% over the following quarter), a 27% trim in Q3 2025 (shares rose 53% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 475.69K | $8.57M | New |
| Q3 2024 | 384.77K | $10.27M | Reduce |
| Q4 2024 | 402.77K | $10.75M | Add |
| Q1 2025 | 320.40K | $7.05M | Reduce |
| Q2 2025 | 716.87K | $9.40M | Add |
| Q3 2025 | 520.24K | $8.44M | Reduce |
| Q4 2025 | 437.82K | $10.86M | Reduce |
| Q1 2026 | 386.50K | $12.17M | Reduce |
| Q2 2026 | 380.92K | $15.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.22M sh · $415.05M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.73M sh · $192.12M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.37M sh · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Siren, L.L.C. 3.18M sh · $129.39M · Q2 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- Integral Health Asset Management, LLC 2.00M sh · $81.26M · Q2 2026
- BRAIDWELL LP 2.00M sh · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held EWTX?
Sofinnova Investments, Inc. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Sofinnova Investments, Inc.'s current position in EWTX?
As of Q2 2026, Sofinnova Investments, Inc. holds 380.92K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $15.48M, representing 0.82% of its reported portfolio and ranking #32.
Has Sofinnova Investments, Inc. been buying or selling EWTX?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. reduced its position in EWTX. The position peaked in Q2 2026 at 380.92K shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.